Effect of putrescine and all-retinoic acid (ATRA) on immature dendritic cell (DC) phenotype

<p><b>Copyright information:</b></p><p>Taken from "Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency"</p><p>Breast Cancer Research 2005;7(3):R326-R335.</p><p>Published online 25 Feb 2005</p><p>PMCID:PMC1143555.</p><p>Copyright © 2005 Gervais et al.; licensee BioMed Central Ltd</p> Cells were collected after immature DC preparation procedure (imm DC; = 11) and treated with 10 mmol/l putrescine (Put; = 10). To putrescine-treated DCs was added 1 μmol/l ATRA (Put + ATRA; = 5). Data are expressed as percentage of cells (with standard error) expressing the HLA-DRLinand HLA-DRLinphenotypes. *< 0.01 versus imm DCs; **< 0.02 versus putrescine-treated imm DCs.